IDEAYA Biosciences shares are trading higher after the company announced Monday's webcast to disclose topline results from the ongoing Phase 2/3 registrational trial.

Benzinga Newsdesk www.benzinga.com Positive 95.0%

Neg 0% Neu 0% Pos 95%

Comments

No comments yet. Be the first!